312
Views
0
CrossRef citations to date
0
Altmetric
Systematic review and meta-analysis

Vitamin B12 deficiency and use of proton pump inhibitors: a systematic review and meta-analysis

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 479-487 | Received 06 Feb 2023, Accepted 14 Apr 2023, Published online: 19 Apr 2023

References

  • Hálfdánarson ÓÖ, Pottegård A, Björnsson ES, et al. Proton-pump inhibitors among adults: a nationwide drug-utilization study. Therap Adv Gastroenterol. 2018;11:1756284818777943.
  • Chinzon D, Domingues G, Tosetto N, et al. Safety of long-term proton pump inhibitors: facts and myths. Arq Gastroenterol. 2022;59(2):219–225.
  • Kozyraki R, Cases O. Vitamin B12 absorption: mammalian physiology and acquired and inherited disorders. Biochimie. 2013;95(5):1002–1007.
  • Carabotti M, Annibale B, Lahner E. Common pitfalls in the management of patients with micronutrient deficiency: keep in mind the stomach. Nutrients. 2021;13(1):208.
  • Attwood SE, Ell C, Galmiche JP, et al. Long-term safety of proton pump inhibitor therapy assessed under controlled, randomised clinical trial conditions: data from the SOPRAN and LOTUS studies. Aliment Pharmacol Ther. 2015;41(11):1162–1174.
  • Swarnakari KM, Bai M, Manoharan MP, et al. The effects of proton pump inhibitors in acid hypersecretion-induced vitamin B12 deficiency: a systematic review. Cureus. 2022;14(11):e31672.
  • Camarero-Shelly M. Niveles de vitamina B12 en la población consultante de un centro de salud urbano de Madrid [Vitamin B12 levels in the patient population attending an urban health centre in Madrid]. Semergen. 2018;44(3):161–167.
  • Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
  • Balduzzi S, Rücker G, Schwarzer G. How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health. 2019;22(4):153–160.
  • Lortie CJ, Filazzola A. A contrast of meta and metafor packages for meta-analyses in R. Ecol Evol. 2020;10(20):10916–10921.
  • Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–605.
  • Gjerdevik M, Heuch I. Improving the error rates of the Begg and Mazumdar test for publication bias in fixed effects meta-analysis. BMC Med Res Methodol. 2014;14:109.
  • Cotter P, O’Keeffe S. Use of proton pump inhibitors is not associated with Vitamin B12 deficiency and in older hospital patients: a case control study. Eur Geriatr Med. 2011;2(4):253–255.
  • den Elzen WP, Groeneveld Y, de Ruijter W, et al. Long-term use of proton pump inhibitors and vitamin B12 status in elderly individuals. Aliment Pharmacol Ther. 2008;27(6):491–497.
  • Dharmarajan TS, Kanagala MR, Murakonda P, et al. Do acid-lowering agents affect vitamin B12 status in older adults? J Am Med Dir Assoc. 2008;9(3):162–167.
  • Dries LS, Haefliger R, Seibert BS, et al. Cognition, oxidative stress and vitamin B12 levels evaluation on patients under long-term omeprazole use. J Pharm Pharmacol. 2022;74(4):547–555.
  • Hartman B, Donnelly-VanderLoo M, Watson T, et al. Proton-pump inhibitor therapy and vitamin B12 status in an inpatient hospital setting. Appl Physiol Nutr Metab. 2016;41(10):1071–1076.
  • Hughes CF, Ward M, Hoey L, et al. Chronic PPI use and vitamin B12 status: is there a role for fortified food? 9th international conference on homocysteine and one-carbon metabolism – HCY2013. J Inherit Metab Dis. 2013;36:S1.
  • Ingole JR, Patel RD, Ingole SJ, et al. Opportunistic screening of vitamin B12 deficiency in IT professionals presenting for routine health check-up. J Clin Diagn Res. 2015;9(12):OC01–2.
  • Lam JR, Schneider JL, Zhao W, et al. Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency. JAMA. 2013;310(22):2435–2442.
  • Lerman TT, Cohen E, Sochat T, et al. Proton pump inhibitor use and its effect on vitamin B12 and homocysteine levels among men and women: a large cross-sectional study [published online ahead of print, 2022 Jul 24]. Am J Med Sci. 2022;S0002-9629(22) p. 00313–5.
  • Lewis JR, Barre D, Zhu K, et al. Long-term proton pump inhibitor therapy and falls and fractures in elderly women: a prospective cohort study. J Bone Miner Res. 2014;29(11):2489–2497.
  • Long AN, Atwell CL, Yoo W, et al. Vitamin B(12) deficiency associated with concomitant metformin and proton pump inhibitor use. Diabetes Care. 2012;35(12):e84. DOI:10.2337/dc12-0980
  • Madigan KE. Sa617 prevalence and association of vitamin B12 deficiency and small intestinal bacterial overgrowth in patients taking proton pump inhibitors. Gastroenterology. 2021;160(6): S–575.
  • Martins JC, Moyses-Neto M, NT B, et al. Vitamin C, vitamin B12, and folic acid blood levels and their association with proton pump inhibitors use in renal transplant recipients. J Am Soc Nephrol. 2019;30:1155.
  • O’Leary F, Wai J, Wormald L, et al. Vitamin B12 status, dietary protein intake and proton pump inhibitor use in geriatric rehabilitation subjects. Nutr Diet. 2011;68:109–114.
  • KM P, Hoey L, CF H, et al. Associations of atrophic gastritis and proton-pump inhibitor drug use with vitamin B-12 status, and the impact of fortified foods, in older adults. Am J Clin Nutr. 2021;114(4):1286–1294.
  • Qorraj-Bytyqi H, Hoxha R, Sadiku S, et al. Proton pump inhibitors intake and iron and vitamin B12 status: a prospective comparative study with a follow up of 12 months. Open Access Maced J Med Sci. 2018;6(3):442–446. DOI:10.3889/oamjms.2018.142
  • Ter Heide H, Hendriks HJ, Heijmans H, et al. Are children with cystic fibrosis who are treated with a proton-pump inhibitor at risk for vitamin B(12) deficiency? J Pediatr Gastroenterol Nutr. 2001;33(3):342–345.
  • Valuck RJ, Ruscin JM. A case-control study on adverse effects: h2 blocker or proton pump inhibitor use and risk of vitamin B12 deficiency in older adults. J Clin Epidemiol. 2004 Apr;57(4):422–428.
  • Rozgony NR, Fang C, Kuczmarski MF, et al. Vitamin B(12) deficiency is linked with long-term use of proton pump inhibitors in institutionalized older adults: could a cyanocobalamin nasal spray be beneficial? J Nutr Elder. 2010;29(1):87–99.
  • Saltzman JR, Kemp JA, Golner BB, et al. Effect of hypochlorhydria due to omeprazole treatment or atrophic gastritis on protein-bound vitamin B12 absorption. J Am Coll Nutr. 1994;13(6):584–591.
  • Termanini B, Gibril F, Sutliff VE, et al. Effect of long-term gastric acid suppressive therapy on serum vitamin B12 levels in patients with Zollinger-Ellison syndrome. Am j med. 1998;104(5):422–430.
  • Presse N, Perreault S, Kergoat MJ. Vitamin B12 deficiency induced by the use of gastric acid inhibitors: calcium supplements as a potential effect modifier. J Nutr Health Aging. 2016;20(5):569–573.
  • Atwell C, Long A, Yoo W, et al. Metformin and proton pump inhibitors effect on vitamin B12 levels.Southern regional. Meeting Abstr J Investig Med. 2012;60:312–466.
  • Clements M, Ward M, Hughes CF, et al. Impact of food-bound malabsorption on vitamin B12 status in older adults from the TUDA ageing cohort study: preliminary findings. Proc Nutr Soc. 2020;79(OCE2):E587.
  • Damião CP, Rodrigues AO, Pinheiro MF, et al. Prevalence of vitamin B12 deficiency in type 2 diabetic patients using metformin: a cross-sectional study. Sao Paulo Med J. 2016;134(6):473–479.
  • Damodharan S, Raj GM, Sakthibalan M, et al. Effect of long-term acid suppression therapy with proton pump inhibitors or H2 receptor blockers on serum vitamin B12 levels in elderly population. Ir J Med Sci. 2021;190(3):1213–1217.
  • Doell A, Walus A, To J, et al. Quantifying candidacy for deprescribing of proton pump inhibitors among long-term care residents. Can J Hosp Pharm. 2018;71(5):302–307.
  • Dougherty T, Sekaran A, Borum M. Chronic proton pump inhibitor use is not associated with vitamin B12 deficiency: 132. Am J Gastroenterol. 2013;108:S42.
  • Ell C, Lundell LR, Seiler CM, et al. W1111 safety profile in GERD patients 5 Yrs after laparoscopic antireflux surgery or long-term treatment with esomeprazole 20-40mg daily in the lotus study. Gastroenterology. 2010;138(5):S–654.
  • Eren M, Hekim S, Sivrikoz I. The impact of long term lansoprazole on serum iron, calcium,Vitamin B12, bone turnover and community acquired pneumonia in children European Society for Paediatric Gastroenterology, Hepatology, and nutrition annual meeting June 9–12, 2010 Istanbul, Turkey. J Pediatr Gastroenterol Nutr. 2010;50:E1–217.
  • Fernandes MA, Torres MT, Borges DD, et al. The proton pump inhibitors use on elderly—a faster way to death? Eur Geriatr Med. 2018;9(S1):1–367.
  • Henriksen DP, Hallas J, Nybo M, et al. Drug-induced vitamin B12 deficiency: a population based hypothesis-free symmetry analysis screening: iCPE All Access conference abstracts. Pharmacoepidemiol Drug Saf. 2020;29(S3):1053–8569.
  • Hughes CF, Ward M, Hoey L, et al. Is there a role of fortified food in maintaining vitamin B12 status in proton pump inhibitor users? Proc Nutr Soc. 2012;71(OCE2):E190.
  • Yousef Khan F, Yousif AB, Suliman A, et al. Association of vitamin B12 deficiency with metformin use in patients with type 2 diabetes treated in the largest tertiary care hospital in Qatar. Qatar Med J. 2021 Sep 9;2021(2):39. DOI:10.5339/qmj.2021.39
  • Koop H, Bachem MG. Serum iron, ferritin, and vitamin B12 during prolonged omeprazole therapy. J Clin Gastroenterol. 1992;14(4):288–292.
  • Luiten VO, Janse A, Donukshe-Rutten R, et al. Is use of medication associated with blood levels of micronutrients? A cross-sectional study of a geriatric hospital population. First national congress on nutritional medicine of the Dutch nutraceutical association. Ann Nutr Metab. 2013;62:146–157.
  • Lukaszuk JM, Walker DA, Shokrani M, et al. Assessment of vitamin B12 tissue stores in elderly proton pump inhibitor users. Cogent Med. 2017;4:1389639.
  • El Menabawey T, Dluzewski S, Phillpotts S, et al. PTU-112 proton pump inhibitors – a risk for micronutrient deficiency. But are we looking out for this? Gut. 2016;65:A111.
  • Nair HP, Kulkarni AR, Eswaran M, et al. Incidence of adverse drug reactions due to inappropriate proton pump inhibitors use: a prospective study. Asian J Pharm Clin Res. 2018;11(11):1–454.
  • Patel AP, Shah N, Munis A, et al. Does gender play a role in how gastroenterology patients view adverse effects of proton pump inhibitors? Am J Gastroenterol. 2020;115:S9–10.
  • Ribeiro RHT, Ribeiro FA, Silva RPM, et al. Depression, hematologic parameters, and blood levels of vitamin B12 in patients with laryngopharyngeal reflux under use of proton pump inhibitors. Clin Med Insights Ear Nose Throat. 2019;12:1179550619828683.
  • Sagar M, Janczewska I, Ljungdahl A, et al. Effect of CYP2C19 polymorphism on serum levels of vitamin B12 in patients on long-term omeprazole treatment. Aliment Pharmacol Ther. 1999;13(4):453–458.
  • Salinas M, López-Garrigós M, Flores E, et al. Primary Care-LABoratory (PRIMLAB) working group. Less is more: two automated interventions to increase vitamin B12 measurement when long-term proton pump inhibitor and decrease redundant testing. Clin Chim Acta. 2020;506:176–179.
  • Schenk BE, Festen HP, Kuipers EJ, et al. Effect of short- and long-term treatment with omeprazole on the absorption and serum levels of cobalamin. Aliment Pharmacol Ther. 1996;10(4):541–545. DOI:10.1046/j.1365-2036.1996.27169000.x
  • Schenk BE, Kuipers EJ, Klinkenberg-Knol EC, et al. Atrophic gastritis during long-term omeprazole therapy affects serum vitamin B12 levels. Aliment Pharmacol Ther. 1999;13(10):1343–1346.
  • Salvo EM, Ferko NC, Cash SB, et al. Umbrella review of 42 systematic reviews with meta-analyses: the safety of proton pump inhibitors. Aliment Pharmacol Ther. 2021 Jul;54(2):129–143.
  • Jung SB, Nagaraja V, Kapur A, et al. Association between vitamin B12 deficiency and long-term use of acid-lowering agents: a systematic review and meta-analysis. Intern Med J. 2015;45(4):409–416.
  • Bavishi C, Dupont HL. Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection. Aliment Pharmacol Ther. 2011;34(11–12):1269–1281.
  • Nassar Y, Richter S. Proton-pump inhibitor use and fracture risk: an updated systematic review and meta-analysis. J Bone Metab. 2018;25(3):141–151.
  • Nochaiwong S, Ruengorn C, Awiphan R, et al. The association between proton pump inhibitor use and the risk of adverse kidney outcomes: a systematic review and meta-analysis. Nephrol Dial Transplant. 2018 Feb 1;33(2):331–342.
  • Savarino V, Dulbecco P, Savarino E. Are proton pump inhibitors really so dangerous? Dig Liver Dis. 2016;48(8):851–859.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.